Table 5 Common prescriptions for acute respiratory symptoms in participants with an acute respiratory illness within the 2 weeks prior to the follow-up assessment
Medication type | Age 8–10 weeks | Age 22–24 weeks | ||
|---|---|---|---|---|
ARI with cough (N = 12) | ARI without cough (N = 17) | ARI with cough (N = 39) | ARI without cough (N = 23) | |
No medication, n (%) | 1 (8) | 1 (6) | 2 (5) | 1 (4) |
Cough medication (Glycerylguaiacolate), n (%) | 5 (42) | 0 (0) | 21 (54) | 4 (17) |
Antihistamine (CTM), n (%) | 3 (25) | 5 (29) | 27 (69) | 10 (44) |
Mucolytic (Ambroxol), n (%) | 0 (0) | 1 (6) | 10 (26) | 4 (17) |
Oral Bronchodilator (Salbutamol), n (%) | 3 (25) | 2 (12) | 6 (15) | 3 (13) |
Antibiotic (Amoxicillin), n (%) | 3 (25) | 1 (6) | 2 (5) | 1 (4) |